Strata Critical Medical (formerly Blade Air Mobility) has completed a fundamental business transformation from passenger air mobility to specialized time-critical medical logistics and healthcare services.
This represents a complete strategic pivot away from the original helicopter passenger transport and eVTOL development business model toward healthcare-focused operations. The dramatic shift in business description, removal of all Electric Vertical Aircraft references, and new risk factors centered on healthcare regulation, cybersecurity, and medical compliance indicate investors are now holding shares in an entirely different company with different market dynamics, regulatory requirements, and growth prospects.
The financial profile reflects the business transformation with revenue declining 21% to $197M while profitability metrics improved meaningfully - gross profit grew 39% and operating losses narrowed substantially. Balance sheet strength increased with cash growing notably and stockholders' equity expanding 26%, though accounts receivable roughly doubled and capital expenditures dropped significantly, suggesting changing working capital dynamics and investment priorities aligned with the new medical logistics focus.
Receivables surged 85.1% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Capex reduced 68.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash position surged 68.5% — strong cash generation or capital raise providing significant financial cushion.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Liabilities grew 33.6% — significant increase in debt or obligations, assess impact on financial flexibility.
Asset base grew 26.8% — expansion through organic growth, acquisitions, or capital deployment.
Equity base grew 25.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Current assets declined 21.5% — monitor working capital adequacy and short-term liquidity.
Revenue softened 20.7% — monitor whether this is cyclical or structural.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →